Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Cardiology
Metadata
Title
Pharmacologic Management of Arrhythmias
Author
M.Th.E. Bink-Boelkens
Publication date
01-11-2000
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 6/2000
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s002460010128

Other articles of this Issue 6/2000

Pediatric Cardiology 6/2000 Go to the issue

OriginalPaper

Radiofrequency Catheter Ablation: Indications and Complications

OriginalPaper

New Directions in Surgical Therapy of Arrhythmias

News

Upcoming Events in Pediatric Cardiology

OriginalPaper

Radiofrequency Catheter Ablation of Tachycardia in Patients with Congenital Heart Disease

Editorial

Electrophysiology for the Pediatric Cardiologist

News

From Other Journals

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits